Cargando…
Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610245/ https://www.ncbi.nlm.nih.gov/pubmed/31316385 http://dx.doi.org/10.3389/fphar.2019.00725 |
_version_ | 1783432468899037184 |
---|---|
author | Nikiforov, Nikita G. Wetzker, Reinhard Kubekina, Marina V. Petukhova, Anna V. Kirichenko, Tatiana V. Orekhov, Alexander N. |
author_facet | Nikiforov, Nikita G. Wetzker, Reinhard Kubekina, Marina V. Petukhova, Anna V. Kirichenko, Tatiana V. Orekhov, Alexander N. |
author_sort | Nikiforov, Nikita G. |
collection | PubMed |
description | Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components of the innate immunity, may precede the local events. In this article, we discuss tolerance, which results in decreased ability of monocytes to be activated by pathogens and other stimuli, and training, the ability of monocyte to potentiate the response to pathological stimuli, and their relation to atherosclerosis. We also present previously unpublished results of the experiments that our group performed with monocytes/macrophages isolated from atherosclerosis patients. Our data allow assuming the existence of relationship between the formation of monocyte training and the degree of atherosclerosis progression. The suppression of trained immunity ex vivo seems to be a perspective model for searching anti-atherogenic drugs. |
format | Online Article Text |
id | pubmed-6610245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66102452019-07-17 Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach Nikiforov, Nikita G. Wetzker, Reinhard Kubekina, Marina V. Petukhova, Anna V. Kirichenko, Tatiana V. Orekhov, Alexander N. Front Pharmacol Pharmacology Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components of the innate immunity, may precede the local events. In this article, we discuss tolerance, which results in decreased ability of monocytes to be activated by pathogens and other stimuli, and training, the ability of monocyte to potentiate the response to pathological stimuli, and their relation to atherosclerosis. We also present previously unpublished results of the experiments that our group performed with monocytes/macrophages isolated from atherosclerosis patients. Our data allow assuming the existence of relationship between the formation of monocyte training and the degree of atherosclerosis progression. The suppression of trained immunity ex vivo seems to be a perspective model for searching anti-atherogenic drugs. Frontiers Media S.A. 2019-06-27 /pmc/articles/PMC6610245/ /pubmed/31316385 http://dx.doi.org/10.3389/fphar.2019.00725 Text en Copyright © 2019 Nikiforov, Wetzker, Kubekina, Petukhova, Kirichenko and Orekhov http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Nikiforov, Nikita G. Wetzker, Reinhard Kubekina, Marina V. Petukhova, Anna V. Kirichenko, Tatiana V. Orekhov, Alexander N. Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title | Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title_full | Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title_fullStr | Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title_full_unstemmed | Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title_short | Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach |
title_sort | trained circulating monocytes in atherosclerosis: ex vivo model approach |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610245/ https://www.ncbi.nlm.nih.gov/pubmed/31316385 http://dx.doi.org/10.3389/fphar.2019.00725 |
work_keys_str_mv | AT nikiforovnikitag trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach AT wetzkerreinhard trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach AT kubekinamarinav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach AT petukhovaannav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach AT kirichenkotatianav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach AT orekhovalexandern trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach |